Literature DB >> 29803385

CT-based radiomic model predicts high grade of clear cell renal cell carcinoma.

Jiule Ding1, Zhaoyu Xing2, Zhenxing Jiang1, Jie Chen1, Liang Pan1, Jianguo Qiu1, Wei Xing3.   

Abstract

PURPOSE: To compare the predictive models that can incorporate a set of CT image features for preoperatively differentiating the high grade (Fuhrman III-IV) from low grade (Fuhrman I-II) clear cell renal cell carcinoma (ccRCC).
MATERIAL AND METHODS: One hundred and fourteen patients with ccRCC treated with a partial or radical nephrectomy were enrolled in the training cohort. The six non-texture features, including Pseudocapsule, Round mass, maximal tumor diameter (Diametermax), intratumoral artery (Arterytumor), enhancement value of the tumor (TEV) and relative TEV (rTEV), were assessed for each tumor. The texture features were extracted from the CT images of the section with the largest area of renal mass at both corticomedullary and nephrographic phases. The least absolute shrinkage and selection operator (LASSO) was used to screen the most valuable texture features to calculate a texture score (Texture-score) for each patient. A logistic regression model was used in the training cohort to discriminate the high from low grade ccRCC at nephrectomy. The predictors would include all non-texture features in Model 1, all non-texture features and Texture-score in Model 2, and Texture-score in Model 3. The performance of the predictive models were tested and compared in an independent validation cohort composed of 92 cases with ccRCC.
RESULTS: Inter-rater agreement was good for each non-texture feature and Texture-score (the concordance correlation coefficient or Kappa coefficient > 0.70). The Texture-score was calculated via a linear combination of the 4 selected texture features. The three models shown good discrimination of the high from low grade ccRCC in the training cohort and the area under receiver operating characteristic curve (AUC) was 0.826 in Mode 1, 0.878 in Model 2 and 0.843 in Model 3, and a significant different AUC was found between Model 1 and Model 2. Application of the predictive models in the validation cohort still gave a discrimination (AUC > 0.670), and the Texture-score based models with or without the non-texture features (Model 2 and 3) showed a better discrimination of the high from low grade ccRCC (P < 0.05).
CONCLUSION: This study presented the Texture-score based models can facilitate the preoperative discrimination of the high from low grade ccRCC.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  CT; Image feature; Image texture; Radiomics; Tomography

Mesh:

Year:  2018        PMID: 29803385     DOI: 10.1016/j.ejrad.2018.04.013

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  40 in total

1.  CT radiomics may predict the grade of pancreatic neuroendocrine tumors: a multicenter study.

Authors:  Dongsheng Gu; Yabin Hu; Hui Ding; Jingwei Wei; Ke Chen; Hao Liu; Mengsu Zeng; Jie Tian
Journal:  Eur Radiol       Date:  2019-06-21       Impact factor: 5.315

Review 2.  [Imaging in individualized uro-oncology].

Authors:  J Bründl; J Breyer; M Burger
Journal:  Urologe A       Date:  2018-09       Impact factor: 0.639

Review 3.  Current and future applications of machine and deep learning in urology: a review of the literature on urolithiasis, renal cell carcinoma, and bladder and prostate cancer.

Authors:  Rodrigo Suarez-Ibarrola; Simon Hein; Gerd Reis; Christian Gratzke; Arkadiusz Miernik
Journal:  World J Urol       Date:  2019-11-05       Impact factor: 4.226

4.  CT texture analysis in the differentiation of major renal cell carcinoma subtypes and correlation with Fuhrman grade.

Authors:  Yu Deng; Erik Soule; Aster Samuel; Sakhi Shah; Enming Cui; Michael Asare-Sawiri; Chandru Sundaram; Chandana Lall; Kumaresan Sandrasegaran
Journal:  Eur Radiol       Date:  2019-05-24       Impact factor: 5.315

5.  MRI radiomics analysis for predicting preoperative synchronous distant metastasis in patients with rectal cancer.

Authors:  Huanhuan Liu; Caiyuan Zhang; Lijun Wang; Ran Luo; Jinning Li; Hui Zheng; Qiufeng Yin; Zhongyang Zhang; Shaofeng Duan; Xin Li; Dengbin Wang
Journal:  Eur Radiol       Date:  2018-11-09       Impact factor: 5.315

Review 6.  Artificial intelligence (AI) in urology-Current use and future directions: An iTRUE study.

Authors:  Milap Shah; Nithesh Naik; Bhaskar K Somani; B M Zeeshan Hameed
Journal:  Turk J Urol       Date:  2020-05-27

7.  A CT-based radiomics nomogram for differentiation of renal angiomyolipoma without visible fat from homogeneous clear cell renal cell carcinoma.

Authors:  Pei Nie; Guangjie Yang; Zhenguang Wang; Lei Yan; Wenjie Miao; Dapeng Hao; Jie Wu; Yujun Zhao; Aidi Gong; Jingjing Cui; Yan Jia; Haitao Niu
Journal:  Eur Radiol       Date:  2019-09-10       Impact factor: 5.315

8.  MRI Radiomics for the Prediction of Fuhrman Grade in Clear Cell Renal Cell Carcinoma: a Machine Learning Exploratory Study.

Authors:  Arnaldo Stanzione; Carlo Ricciardi; Renato Cuocolo; Valeria Romeo; Jessica Petrone; Michela Sarnataro; Pier Paolo Mainenti; Giovanni Improta; Filippo De Rosa; Luigi Insabato; Arturo Brunetti; Simone Maurea
Journal:  J Digit Imaging       Date:  2020-08       Impact factor: 4.056

9.  Reproducibility of CT-based radiomic features against image resampling and perturbations for tumour and healthy kidney in renal cancer patients.

Authors:  Margherita Mottola; Alessandro Bevilacqua; Stephan Ursprung; Leonardo Rundo; Lorena Escudero Sanchez; Tobias Klatte; Iosif Mendichovszky; Grant D Stewart; Evis Sala
Journal:  Sci Rep       Date:  2021-06-02       Impact factor: 4.379

10.  Shape and texture-based radiomics signature on CT effectively discriminates benign from malignant renal masses.

Authors:  Felix Y Yap; Bino A Varghese; Steven Y Cen; Darryl H Hwang; Xiaomeng Lei; Bhushan Desai; Christopher Lau; Lindsay L Yang; Austin J Fullenkamp; Simin Hajian; Marielena Rivas; Megha Nayyar Gupta; Brian D Quinn; Manju Aron; Mihir M Desai; Monish Aron; Assad A Oberai; Inderbir S Gill; Vinay A Duddalwar
Journal:  Eur Radiol       Date:  2020-08-15       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.